Skip to main content
Premium Trial:

Request an Annual Quote

Agilent Certifies BGI as Provider for SureSelect XT Target Enrichment System

By a GenomeWeb Staff Reporter

NEW YORK (GenomeWeb News) – Agilent Technologies today announced BGI has become a certified service provider for Agilent's SureSelect XT Target Enrichment System for next-generation sequencing.

Based in Shenzhen, China, BGI becomes the first SureSelect XT CSF in that country, and is certified for all SureSelect XT target enrichment protocols, including human all-exon, SureSelect indexing, DNA capture, RNA capture, kinome RNA, and custom kits.

The platform was launched in 2009 and Agilent currently offers 35 SureSelect Target Enrichment kits, it said.